Dual anti-platelet therapy remains a cornerstone of the treatment for coronary artery disease. When choosing a second anti-platelet, ticagrelor remains a principal agent after the recent PLATO trial ...
Introduction Human papillomavirus (HPV) vaccines have been introduced in the Chinese market since 2016. However, the HPV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback